This brand name is authorized in Austria, Cyprus, Germany, Estonia, Spain, Finland, France, Ireland, Israel, Italy, Lithuania, Malta, Mexico, Nigeria, Netherlands, Poland, Romania, Tunisia, Turkey, South Africa
The drug TAVANIC contains one active pharmaceutical ingredient (API):
1
Levofloxacin hemihydrate
UNII 6GNT3Y5LMF - LEVOFLOXACIN
|
Levofloxacin is a synthetic antibacterial agent of the fluoroquinolone class. As a fluoroquinolone antibacterial agent, levofloxacin acts on the DNA – DNA-gyrase complex and topoisomerase IV. |
Below package inserts are available for further reading:
Title | Information Source | Document Type | |
---|---|---|---|
TAVANIC Film-coated tablet | Health Products Regulatory Authority (IE) | MPI, EU: SmPC |
This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:
ATC code | Group title | Classification |
---|---|---|
J01MA12 | Levofloxacin | J Antiinfectives for systemic use → J01 Antibacterials for systemic use → J01M Quinolone antibacterials → J01MA Fluoroquinolones |
This drug has been assigned below unique identifiers within the countries it is being marketed:
Country | Identification scheme | Identifier(s) |
---|---|---|
Country: DE | Bundesinstitut für Arzneimittel und Medizinprodukte | Identifier(s): 08586241, 08586264, 08586270, 08752627 |
Country: EE | Ravimiamet | Identifier(s): 1102723, 1102734, 1102745, 1102756, 1102767, 1102778, 1102789, 1102790, 1102802, 1102813, 1102824, 1102857, 1102868, 1141669, 1144583, 1144594, 1144606, 1295681, 1295759, 1736636 |
Country: ES | Centro de información online de medicamentos de la AEMPS | Identifier(s): 62065 |
Country: FI | Lääkealan turvallisuus- ja kehittämiskeskus | Identifier(s): 076950, 375259, 510564 |
Country: FR | Base de données publique des médicaments | Identifier(s): 64784789, 69091027 |
Country: IE | Health Products Regulatory Authority | Identifier(s): 56911, 56938, 56965 |
Country: IL | מִשְׂרַד הַבְּרִיאוּת | Identifier(s): 4191 |
Country: IT | Agenzia del Farmaco | Identifier(s): 033634015, 033634039 |
Country: LT | Valstybinė vaistų kontrolės tarnyba | Identifier(s): 1009238, 1009239, 1009240, 1009242, 1009243, 1009244, 1009245, 1009246, 1009247, 1068231, 1068232, 1068233, 1068234, 1068235, 1068236, 1068237, 1068238, 1068239, 1068240, 1068241 |
Country: MT | Medicines Authority | Identifier(s): MA1359/03801, PI908/07801A |
Country: MX | Comisión Federal para la Protección contra Riesgos Sanitarios | Identifier(s): 391M97, 392M97 |
Country: NG | Registered Drug Product Database | Identifier(s): 04-3143, 04-5409 |
Country: NL | Z-Index G-Standaard, PRK | Identifier(s): 97500 |
Country: PL | Rejestru Produktów Leczniczych | Identifier(s): 100101867 |
Country: RO | Agenția Națională a Medicamentului și a Dispozitivelor Medicale | Identifier(s): W55699001, W55699002, W55699003, W55699004, W55700001, W55700002, W55700003, W55701001, W55702001 |
Country: TN | Direction de la Pharmacie et du Médicament | Identifier(s): 5363041H, 9263141, 9263142 |
Country: TR | İlaç ve Tıbbi Cihaz Kurumu | Identifier(s): 8699809097667, 8699809690233 |
Country: ZA | Health Products Regulatory Authority | Identifier(s): 32/20.1.1/0123, 32/20.1.1/0124, 32/20.1.1/0125, 34/20.1.1/0002, 43/20.1.1/0947, 43/20.1.1/0948 |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.